The impact of respiratory gated positron emission tomography on clinical staging and management of patients with lung cancer

Lung Cancer

Volumn 90, Issue 2, 2015, Pages 217-223

  Grootjans, Willem ^a   Hermsen, Rick ^a   van der Heijden, Erik H F M ^a   Schuurbiers Siebers, Olga C J ^a   Visser, Eric P ^a   Oyen, Wim J G ^a,b   de Geus Oei, Lioe Fee ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Lung cancer; Optimal respiratory gating; Patient management; PET CT; 18F fluorodeoxyglucose

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHEMORADIOTHERAPY; DIAGNOSTIC ACCURACY; FEMALE; HILAR LYMPH NODE; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; NON SMALL CELL LUNG CANCER; PARAAORTIC LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RESPIRATORY GATED IMAGING; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; ARTIFACT; LUNG TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; PROCEDURES; SCINTISCANNING; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ARTIFACTS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84955340004     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.09.016     Document Type: Article

References (25)

1. Grootjans W., de Geus-Oei L.-F., Troost E.G.C., Visser E.P., Oyen W.J.G., Bussink J. PET in the management of locally advanced and metastatic NSCLC. Nat. Rev. Clin. Oncol. 2015, 12:395-407.
2. Schrevens L., Lorent N., Dooms C., Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 2004, 9:633-643.
3. Verhagen A.F.T., Bootsma G.P., Tjan-Heijnen V.C.G., van der Wilt G.J., Cox A.L., Brouwer M.H.J., Corstens F.H.M., Oyen W.J.G. FDG-PET in staging lung cancer: how does it change the algorithm?. Lung Cancer 2004, 44:175-181.
4. van Tinteren H., Hoekstra O.S., Smit E.F., van den Bergh J.H.A.M., Schreurs A.J.M., Stallaert R.A.L.M., van Velthoven P.C.M., Comans E.F.I., Diepenhorst F.W., Verboom P., van Mourlk J.C., Postmus P.E., Boers M., Teule G.J.J. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002, 359:1388-1392.
5. Shim S.S., Lee K.S., Kim B.-T., Chung M.J., Lee E.J., Han J., Choi J.Y., Kwon O.J., Shim Y.M., Kim S. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005, 236:1011-1019.
6. Fischer B., Lassen U., Mortensen J., Larsen S., Loft A., Bertelsen A., Ravn J., Clementsen P., Høgholm A., Larsen K., Rasmussen T., Keiding S., Dirksen A., Gerke O., Skov B., Steffensen I., Hansen H., Vilmann P., Jacobsen G., Backer V., Maltbæk N., Pedersen J., Madsen H., Nielsen H., Højgaard L. Preoperative staging of lung cancer with combined PET-CT. N. Engl. J. Med. 2009, 361:32-39.
7. Eschmann S.M., Friedel G., Paulsen F., Reimold M., Hehr T., Scheiderbauer J., Budach W., Kotzerke J., Bares R. Impact of staging with 18F-FDG-PET on outcome of patients with stage III non-small cell lung cancer: PET identifies potential survivors. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:54-59.
8. De Leyn P., Lardinois D., Van Schil P.E., Rami-Porta R., Passlick B., Zielinski M., Waller D.A., Lerut T., Weder W. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur. J. Cardiothorac. Surg. 2007, 32:1-8.
9. Vansteenkiste J., De Ruysscher D., Eberhardt W.E.E., Lim E., Senan S., Felip E., Peters S. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013.
10. Früh M., De Ruysscher D., Popat S., Crinò L., Peters S., Felip E. Group obotEGW. Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2013.
11. Grootjans W., de Geus-Oei L.-F., Meeuwis A.W., van der Vos C., Gotthardt M., Oyen W.G., Visser E. Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer. Eur. Radiol. 2014, 24:3242-3250.
12. Stine S.K. Motion in radiotherapy: photon therapy. Phys. Med. Biol. 2012, 57:R161.
13. Nehmeh S.A., Erdi Y.E., Pan T., Pevsner A., Rosenzweig K.E., Yorke E., Mageras G.S., Schoder H., Vernon P., Squire O., Mostafavi H., Larson S.M., Humm J.L. Four-dimensional (4D) PET/CT imaging of the thorax. Med. Phys. 2004, 31:3179-3186.
14. Dawood M., Büther F., Lang N., Schober O., Schäfers K.P. Respiratory gating in positron emission tomography: a quantitative comparison of different gating schemes. Med. Phys. 2007, 34:3067-3076.
15. Carney J.P.J., Townsend D.W., Rappoport V., Bendriem B. Method for transforming CT images for attenuation correction in PET/CT imaging. Med. Phys. 2006, 33:976-983.
16. van Elmpt W., Hamill J., Jones J., De Ruysscher D., Lambin P., Öllers M. Optimal gating compared to 3D and 4D PET reconstruction for characterization of lung tumours. Eur. J. Nucl. Med. Mol. Imaging 2011, 38:843-855.
17. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., Postmus P.E., Rusch V., Sobin L. Committee obotIAftSoLCIS, institutions P. the IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J. Thorac. Oncol. 2007, 2:706-714.
18. Landis J.G.G.K. The Measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
19. van der Vos C.S., Grootjans W., Meeuwis A.P.W., Slump C.H., Oyen W.J.G., de Geus-Oei L.-F.F., Visser E.P. Comparison of a free-breathing CT and an expiratory breath-hold CT with regard to spatial alignment of amplitude-based respiratory-gated PET and CT images. J. Nucl. Med. Technol. 2014, 42:269-273.
20. Büther F., Ernst I., Dawood M., Kraxner P., Schäfers M., Schober O., Schäfers K. Detection of respiratory tumour motion using intrinsic list mode-driven gating in positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:2315-2327.
21. Bundschuh R.A., Martínez-Moeller A., Essler M., Martínez M.-J., Nekolla S.G., Ziegler S.I., Schwaiger M. Postacquisition detection of tumor motion in the lung and upper abdomen using list-mode PET data: a feasibility study. J. Nucl. Med. 2007, 48:758-763.
22. Kesner A.L., Kuntner C. A new fast and fully automated software based algorithm for extracting respiratory signal from raw PET data and its comparison to other methods. Med. Phys. 2010, 37:5550-5559.
23. Lamare F., Ledesma Carbayo M., Cresson T., Kontaxakis G., Santos A., Cheze Le Rest C., Reader A., Visvikis D. List-mode-based reconstruction for respiratory motion correction in PET using non-rigid body transformations. Phys. Med. Biol. 2007, 52:5187.
24. 18F-fluorodeoxyglucose positron emission tomography and contrast-enhanced CT in a rapid outpatient diagnostic program for patients with suspected lung cancer. Respiration 2014, 87:32-37.
25. Molina J.R., Yang P., Cassivi S.D., Schild S.E., Adjei A.A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 2008, 83:584-594.